| Clinical Indicators
Acoustic Neuroma Surgery
| Approach Procedure |
CPT |
FUD |
| Infratemporal post-auricular approach to middle
cranial fossa |
61591 |
90 |
| Transtemporal approach to posterior cranial fossa
|
61595 |
90 |
| Transcochlear approach to posterior cranial fossa
|
61596 |
90 |
| Transpetrosal approach to posterior cranial fossa
|
61598 |
90 |
| Craniectomy for cerebellopontine angle tumor |
61520 |
90 |
| Craniectomy, transtemporal for excision of
cerebellopontine angle tumor |
61526 |
90 |
Combined with middle/posterior fossa craniotomy/
craniectomy |
61530 |
90 |
| Definitive Procedure |
CPT |
FUD |
| Resection of neoplasm, petrous apex, intradural,
including dural repair |
61606 |
90 |
| Resection of neoplasm, posterior cranial fossa,
intradural, including repair |
61616 |
90 |
| Microdissection, intracranial |
61712 |
90 |
| Stereotactic radiosurgery |
61793 |
90 |
| Decompression internal auditory canal |
69960 |
90 |
| Removal of tumor, temporal bone middle fossa
approach |
69970 |
90 |
| Repair Procedure |
CPT |
FUD |
| Secondary repair of dura for CSF leak, posterior
fossa, by free tissue graft |
61618 |
90 |
| Secondary repair of dura for CSF leak, by local or
regional flap or myocutaneous flap |
61619 |
90 |
| Decompression facial nerve, intratemporal; lateral
to geniculate ganglion |
69720 |
90 |
| Total facial nerve decompression and/or repair
(may include graft) |
69955 |
90 |
| Abdominal fat graft |
20926 |
90 |
| Fascia lata graft; by stripper |
20920 |
90 |
| Fascia lata graft; by incision and area exposure,
complex or sheet |
20922 |
90 |
| Intraoperative Nerve Monitoring
Procedure |
CPT |
FUD |
| Auditory nerve monitoring, setup |
92585 |
90 |
| Intraoperative neurophysiology testing, hourly |
95920 |
90 |
| Facial nerve monitoring, setup |
95925 |
90 |
Indications
1. History
| a) |
Auditory complaints
hearing loss
fullness
distorted sound perception |
| b) |
Tinnitus
ringing
humming
hissing
crickets |
| c) |
Disequilibrium
unsteadiness
dizziness
imbalance
vertigo |
| d) |
Headache |
| e) |
Fifth and seventh cranial nerve symptoms
facial pain
facial tingling, numbness
tics
weakness |
| f) |
Family history of neurofibromatosis type II |
| g) |
Diplopia |
| h) |
Dysarthria, dysphasia, aspiration, hoarseness |
2. Physical Examination
| a) |
Complete head and neck examination |
| b) |
Cranial nerve examination, in particular:
tuning fork lateralization
nystagmus
facial hypesthesia
ear canal hypesthesia
corneal reflex
facial nerve function
extraocular movements
papilledema |
| c) |
Cerebellar examination
Romberg
gait
tandem gait |
3. Preoperative Tests
| a) |
Imaging (one is required demonstrating tumor)
MRI with gadolinium
CT scan, contrast-enhanced |
| b) |
Audiologic
audiogram (pure-tone and speech discrimination)
ABR (auditory brainstem response) |
| c) |
Vestibular
ENG (electronystagmography) |
| d) |
Facial Nerve
EEMG (evoked electromyography) |
Postoperative Observations
| 1. |
Neurological and/or mental status changes suggestive of
cerebral edema. |
| 2. |
Cerebrospinal fluid leakspressure dressings, bed rest,
elevated head-of-bed, lumbar catheter (monitor output). |
| 3. |
Hematoma (cerebellopontine angle, epidural)drainage,
pressure dressings, neurological checks. |
| 4. |
Headache, nuchal rigidity, or feversuggestive of
meningitis. |
| 5. |
Tuning fork test to evaluate hearing. |
| 6. |
Facial paresisprotect cornea. |
| 7. |
Monitor intake and output to detect inappropriate antidiuretic
hormone syndrome. |
| 8. |
Bleeding at wound sitesreinforce dressings. |
Outcome Review
1. One Week
| a) |
dizziness and unsteadiness |
| b) |
hearing levelaudiogram when able |
| c) |
facial functionHouse-Brackmann Grade |
| d) |
wound healing |
| e) |
donor site, if appropriate |
2. Beyond One Month
| a) |
headache |
| b) |
hearing levelaudiometric documentation |
| c) |
facial functionHouse-Brackmann Grade |
| d) |
MRI for residual tumor |
| e) |
Follow up MRI after subtotal resection, as indicated |
Associated ICD-9 Diagnostic Codes
| 225.1 |
Benign neoplasm of cranial nerve |
| 237.72 |
Neurofibromatosis, type 2 |
| 379.50 |
Nystagmus, unspecified |
| 386 |
Vertiginous syndrome and other disorders of the
vestibular system |
| 386.10 |
Other unspecified peripheral vertigo |
| 388.31 |
Subjective tinnitus |
| 388.41 |
Diplacusis |
| 388.42 |
Hypercusis |
| 388.43 |
Impairment of auditory discrimination |
| 388.44 |
Recruitment |
| 388.7 |
Otalgia |
| 389.12 |
Neural hearing loss |
| 350.1 |
Trigeminal neuralgia |
| 351.0 |
Facial paresis/paralysis |
| 368.2 |
Diplopia |
| 780.4 |
Dizziness and giddiness |
| 781.3 |
Lack of coordination |
| 784.0 |
Headache |
| 784.49 |
Hoarseness |
| 784.5 |
Dysarthria, dysphasia |
| 787.2 |
Dysphagia |
Additional Information
Co-Surgeon -- Neurosurgeon as needed
Assistant Surgeon -- Varies by procedure
Supply Charges -- N
Anesthesia Code(s)
00120, 00210
Patient Information
Acoustic neuroma is a benign tumor involving the hearing and balance nerve at
the base of the brain. Its incidence is about 1 per 100,000 people per year.
Acoustic neuromas do not spread throughout the body, but can cause significant
disability, even death, by local growth into nearby important brain structures.
Early symptoms of an acoustic neuroma include hearing loss, distorted sound
perception, tinnitus, dizziness, and disequilibrium. Later symptoms include
headache, unsteadiness, facial pain, tingling, or numbness, facial tics or
weakness, double vision, and difficulty in swallowing or talking.
There are a number of tests that can be utilized to diagnose acoustic
neuromas, the utility of which should be based upon a complete history and
physical by an experienced physician. The definitive diagnostic test is an MRI
with gadolinium enhancement. However, this is a very expensive examination that
should not be used as a screening test, bypassing appropriate clinical
evaluation, hearing, and balance testing.
Treatment options include observation with serial MRIs, partial or total
surgical removal, and radiation therapy. The treatment depends upon the
patient's symptoms, hearing level, health status, age, and the growth rate of
the tumor.
Surgery is the treatment of choice for the majority of acoustic neuromas
requiring intervention. There are three basic approaches: (1) through the
temple, (2) through the ear, and (3) through the back of the head. The approach
used depends upon the size and location of the tumor, the status of the
preoperative hearing, and the experience and preference of the surgeon. The
optimal treatment goal is removal of the tumor while maintaining existing
hearing and facial function. In many cases, hearing in the affected ear cannot
be preserved. Since acoustic neuromas are usually slow growing, partial tumor
removal may be elected by the surgeon to reduce surgical time and preserve
facial function. For those patients unable or unwilling to undergo surgery,
radiation therapy or observation with yearly MRI scans may be alternatives.
Possible complications that may require further medical and/or surgical
rehabilitation include: hearing loss, dizziness, facial weakness or paralysis,
prolonged headaches, fluid leak from around the brain, and tumor recurrence.
Important Notice
The Clinical Indicators for Otolaryngology--Head and Neck Surgery
are guidelines only. In no sense do they represent a standard of care. The
applicability of an indicator for a procedure, and/or of the process or outcome
criteria, must be determined by the responsible physician in light of all the
circumstances presented by the individual patient. Adherence to these
guidelines will not ensure successful treatment in every situation. The
American Academy of Otolaryngology-Head and Neck Surgery, Inc. emphasizes that
these clinical indicators should not be deemed inclusive of all proper
treatment decisions or methods of care, nor exclusive of other treatment
decisions or methods of care reasonably directed to obtaining the same
results.
© 2000 American Academy of Otolaryngology-Head and Neck Surgery. One
Prince Street, Alexandria, VA 22314.
|